Robert L. Grossman ^{^}

• Represented Frost Group in an investment in Protalix and in the transaction by which Protalix became a public company.
• Represented UBS in a public offering of Protalix Ltd.
• Represented Prolor Biotech, Inc. in a public offering.
• Represented various underwriters in public offerings, including public offerings of Israeli companies.
• Representing Galmed Pharmaceuticals, Ltd. in its initial public offering.
• Represented Integrity Applications, Inc. in becoming a publicly reporting company.
• Represented Intec Pharma Ltd. in its initial public offering and in a secondary public offering.
• Represented Glasses Off, Inc. in a reverse merger and private placement pursuant to which the Company went public.
• Represented an Israeli pharmaceutical company in listing Level II ADRs.
• Represented an Israeli company public in Singapore in listing Level I ADRs.
• Represented Castle Brands, Inc. in an ATM offering.
• Represented an Israeli medical device company in a $150 million private placement.
• Represented Intec Pharma Ltd. in a $10 million private placement.
• Represented Castle Brands, Inc., developer and international marketer of premium and super premium alcoholic beverage brands, in a private placement (PIPE) of convertible preferred stock and warrants to various investors, including the conversion of various tranches of the issuer’s existing debt into preferred stock.
• Represented Enlivex Therapeutics Ltd. in various private placements.
• Represented Integrity Applications in various private placements.
• Represented Autobrain Inc. in private placements.
• Represented numerous U.S., Israeli and other private life science and technology companies in various private placements.
• Represented Orbimed Israel in PIPE investment in Red Hill BioPharma Ltd.
• Represented Orbimed Israel in registered direct investment in BiolineRx, Ltd.
• Represented Orbimed Israel in its investment in FUSMobile, Inc.
• Represented various public companies as outside securities counsel.

• Represented IVAX Corporation in its merger with TEVA Pharmaceutical Industries Ltd.
• Represented a leading pharmaceutical company in a $2.3 billion acquisition.
• Represented OPKO Health, Inc. in the $1.4 billion acquisition of Bioreference Labs.
• Represented Prolor Biotech, Inc. in its acquisition by OPKO Health, Inc.
• Represented a mobile virtual network operator (MVNO), a subsidiary of a public company, with its approximately $120 million acquisition of substantially all of the assets and assumption of certain of the liabilities of another MVNO that provides prepaid SIM cards to its customers.
• Represented the representative of the shareholders of Beeologics in its sale of all the stock of Beeologics Holdings Limited, a Cyprus entity, and Beeologics, Inc., a BVI entity, to Monsanto Company.
• Represented a Japanese public technology company in the acquisition of an Israeli technology company for over $200 million.
• Represented Scivac Ltd. in its merger with Levon Resources Ltd.
• Representing Scivac Ltd. in its acquisition of VBI Vaccines Inc 8.
• Represented OPKO Health, Inc. (NYSE: OPK) in connection with its acquisition of Claros Diagnostics, Inc. a private company engaged in the development and marketing of medical diagnostic devices.
• Represented OPKO Health, Inc. in an investment in RXI Pharmaceuticals and the transfer of certain technology and sale of certain assets to RXI.
• Represented Ladenburg Thalmann Financial Services, Inc. in its acquisition of Securities America and its subsidiaries.
• Represented a private equity firm in its sale of 87 Wendy’s franchises.
• Represented Devcon International Corp. in its acquisition of Adelphia electronic security services assets.
• Represented Israeli pharmaceutical company Immune Pharmaceuticals Ltd. in a reverse triangular merger with EpiCept Corporation, a U.S. and Swedish publicly traded biopharmaceutical company, whereby Immune became a wholly owned subsidiary of, and Immune’s shareholders obtained a controlling interest in, EpiCept, which is now known as Immune Pharmaceuticals Inc.
• Represented various life science companies in license and distribution agreements and corporate transactions and matters.
• Represented Orthodontix, Inc. and The Frost Group in a reverse merger with and investment into Protalix Ltd. pursuant to which Protalix became a publicly reporting company.

• Listed, The Best Lawyers in America, International Mergers & Acquisitions, 2019
• Selected, LMG Life Sciences, "Life Science Star," 2016-2018
• Selected, Daily Business Review, "Top Dealmaker of the Year – Corporate Domestic Category," 2016
• Listed, South Florida Legal Guide, "Top Lawyer," 2007-2016
• Listed, Chambers Global, Corporate/M&A, 2011-2019
  • Foreign Experts – USA, 2011-2018
  • Experts Based Abroad - Israel, 2011-2019
• Recognized, BDICoface 2016-2017 (Israel), International Commercial – Outstanding Leaders, 2016-2017
• Recognized, Dun’s 100, 2016-2017 (Israel), International Commercial – Prominent Team, 2016-2017
• Recognized, IFLR, Corporate & M&A, Israel, Other Notable, 2017
• Recognized, The Legal 500: Europe, Middle East & Africa > Israel: Commercial, corporate and M&A, 2017
• Listed, Martindale-Hubbell and ALM, "2013 Top Rated Lawyer" – Securities Law, 2013
• Team Member, Corporate Board Member magazine and FTI Consulting Inc., one of "America’s Best Corporate Law Firms," 13th Annual Legal Industry Study, 2013
• Listed, Chambers & Partners USA Guide, "Top Corporate/M&A Lawyer in Florida," 2006-2008, 2013
• Member, team ranked as a top corporate law firm in Miami as selected by corporate directors, in the annual "Legal Industry Research Study" by Corporate Board Member magazine and FTI Consulting Inc. (10th year), 2002-2009, 2011-2012
• Finalist, Daily Business Review, "Top Dealmaker of the Year – Corporate (Domestic) Category," 2012
• Recommended, PLC Which Lawyer? Yearbook, 2009
• Listed, Super Lawyers magazine, Florida Super Lawyers, 2006
• Listed, Daily Business Review, "South Florida's Top Dealmakers of the Year in Mergers & Acquisitions," 2005
• Recipient, "Put Something Back Corporate Award," Eleventh Judicial Circuit and Dade County Bar Association, 2003
• Recipient, Greater Miami Jewish Federation
• "Stanley C. Myers Presidents' Leadership Award," 1999
• "Robert Russell Leadership Award," 1998
• Listed, South Florida Business Review, "Most Effective Lawyers"
• Rated, AV Preeminent® 5.0 out of 5

°AV^®, AV Preeminent^®, Martindale-Hubbell Distinguished^SM and Martindale-Hubbell Notable^SM are certification marks used under license in accordance with the Martindale-Hubbell^® certification procedures, standards and policies.

• Committee member, Temple Beth Am Israel 
• Member, Greater Miami Jewish Federation, Yerucham Development Committee, 2007-2013
  • Board Member, Board of Directors and Executive Committee
  • Chairman, Agency, Day School and Synagogue Campaign, 2003-2005
  • Past Chairman, South Dade Branch
• Board Member, Project Interchange, Board of Directors, 2005-2013
• Board Member, Jewish National Fund, Board of Directors, 2005-Present
• Board Member, Children's Bereavement Center, Board of Directors, 2001-Present
• Delegation Member, Florida Governor Ron DeSantis Business Development Mission to Israel, 2019
• Board Member, Temple Beth Am, Board of Directors, 2003-2005
• Chairman, Executive Institute of Organization for Leadership Advancement in Miami, 2001-2003
• Chairman, South Dade Israel Task Force (formed first Victims of Terror in Israel Fund and developed South Dade Israel Awareness Week), 2001-2003
• Member, Florida Bar, Corporate Law Subcommittee, 1995-1997
• Member, American Bar Association
• Member, Dade County Bar Association
• Past Chairman and Co-Founder, South Dade Jewish Leadership Council
• Past Chairman, National UJA Young Leadership Cabinet, Miami Division
• Past Member, Dave and Mary Alper Jewish Community Center, Board of Directors and Executive Committee
• Past Member, The Beacon Council, Executive Committee